|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maghfoor I and Perry MC: Lung cancer. Ann
Saudi Med. 25:1–12. 2005.PubMed/NCBI
|
|
3
|
Hanna N, Neubauer M, Yiannoutsos C,
McGarry R, Arseneau J, Ansari R, Reynolds C, Govindan R, Melnyk A,
Fisher W, et al: Hoosier Oncology Group; US Oncology: Phase III
study of cisplatin, etoposide, and concurrent chest radiation with
or without consolidation docetaxel in patients with inoperable
stage III non-small-cell lung cancer: The Hoosier Oncology Group
and US Oncology. J Clin Oncol. 26:5755–5760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Messerschmidt DM, de Vries W, Ito M,
Solter D, Ferguson-Smith A and Knowles BB: Trim28 is required for
epigenetic stability during mouse oocyte to embryo transition.
Science. 335:1499–1502. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barde I, Rauwel B, Marin-Florez RM,
Corsinotti A, Laurenti E, Verp S, Offner S, Marquis J, Kapopoulou
A, Vanicek J, et al: A KRAB/KAP1-miRNA cascade regulates
erythropoiesis through stage-specific control of mitophagy.
Science. 340:350–353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pfeifer GP: Protein phosphatase PP4: Role
in dephosphorylation of KAP1 and DNA strand break repair. Cell
Cycle. 11:2590–2591. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
White DE, Negorev D, Peng H, Ivanov AV,
Maul GG and Rauscher FJ III: KAP1, a novel substrate for PIKK
family members, colocalizes with numerous damage response factors
at DNA lesions. Cancer Res. 66:11594–11599. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gilmore-Hebert M, Ramabhadran R and Stern
DF: Interactions of ErbB4 and Kap1 connect the growth factor and
DNA damage response pathways. Mol Cancer Res. 8:1388–1398. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu C, Zhang S, Gao X, Gao X, Xu X, Lv Y,
Zhang Y, Zhu Z, Zhang C, Li Q, et al: Roles of Kruppel-associated
box (KRAB)-associated co-repressor KAP1 Ser-473 phosphorylation in
DNA damage response. J Biol Chem. 287:18937–18952. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin LF, Li CF, Wang WJ, Yang WM, Wang DD,
Chang WC, Lee WH and Wang JM: Loss of ZBRK1 contributes to the
increase of KAP1 and promotes KAP1-mediated metastasis and invasion
in cervical cancer. PLoS One. 8:e730332013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Addison JB, Koontz C, Fugett JH, Creighton
CJ, Chen D, Farrugia MK, Padon RR, Voronkova MA, McLaughlin SL,
Livengood RH, et al: KAP1 promotes proliferation and metastatic
progression of breast cancer cells. Cancer Res. 75:344–355. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fitzgerald S, Sheehan KM, O'Grady A, Kenny
D, O'Kennedy R, Kay EW and Kijanka GS: Relationship between
epithelial and stromal TRIM28 expression predicts survival in
colorectal cancer patients. J Gastroenterol Hepatol. 28:967–974.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yokoe T, Toiyama Y, Okugawa Y, Tanaka K,
Ohi M, Inoue Y, Mohri Y, Miki C and Kusunoki M: KAP1 is associated
with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol.
17:821–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Zhu C, Guo Y, Wei F, Lu J, Qin J,
Banerjee S, Wang J, Shang H, Verma SC, et al: Inhibition of KAP1
enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus
reactivation through RBP-Jκ. J Virol. 88:6873–6884. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu L, Zhao E, Li C, Huang L, Xiao L,
Cheng L, Huang X, Song Y and Xu D: TRIM28, a new molecular marker
predicting metastasis and survival in early-stage non-small cell
lung cancer. Cancer Epidemiol. 37:71–78. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang C, Rauscher FJ III, Cress WD and Chen
J: Regulation of E2F1 function by the nuclear corepressor KAP1. J
Biol Chem. 282:29902–29909. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meng RD, Phillips P and El-Deiry WS:
p53-independent increase in E2F-1 expression enhances the cytotoxic
effects of etoposide and of adriamycin. Int J Oncol. 14:5–14.
1999.PubMed/NCBI
|
|
18
|
White D, Rafalska-Metcalf IU, Ivanov AV,
Corsinotti A, Peng H, Lee SC, Trono D, Janicki SM and Rauscher FJ
III: The ATM substrate KAP1 controls DNA repair in heterochromatin:
Regulation by HP1 proteins and serine 473/824 phosphorylation. Mol
Cancer Res. 10:401–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang C, Ivanov A, Chen L, Fredericks WJ,
Seto E, Rauscher FJ III and Chen J: MDM2 interaction with nuclear
corepressor KAP1 contributes to p53 inactivation. EMBO J.
24:3279–3290. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kamitani S, Ohbayashi N, Ikeda O, Togi S,
Muromoto R, Sekine Y, Ohta K, Ishiyama H and Matsuda T: KAP1
regulates type I interferon/STAT1-mediated IRF-1 gene expression.
Biochem Biophys Res Commun. 370:366–370. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang C, Martin S, Pfleger C, Du J,
Buckner JH, Bluestone JA, Riley JL and Ziegler SF: Cutting Edge: A
novel, human-specific interacting protein couples FOXP3 to a
chromatin-remodeling complex that contains KAP1/TRIM28. J Immunol.
190:4470–4473. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nip J, Strom DK, Fee BE, Zambetti G,
Cleveland JL and Hiebert SW: E2F-1 cooperates with topoisomerase II
inhibition and DNA damage to selectively augment p53-independent
apoptosis. Mol Cell Biol. 17:1049–1056. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong YB, Yang HL, Elliott MJ and McMasters
KM: Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma
cells to apoptosis induced by topoisomerase II inhibitors. Cancer
Res. 62:1776–1783. 2002.PubMed/NCBI
|
|
24
|
Okamoto K, Kitabayashi I and Taya Y: KAP1
dictates p53 response induced by chemotherapeutic agents via Mdm2
interaction. Biochem Biophys Res Commun. 351:216–222. 2006.
View Article : Google Scholar : PubMed/NCBI
|
